CN Mobile Logo


Oncology and Hematology News and Journal Articles

2015 European Cancer Congress

Cancer Network presents exclusive coverage from the 2015 European Cancer Congress (ECC), held September 25–29 in Vienna.


Recent Content

The US Food and Drug Administration expanded the approval of the anti-PD-1 immunotherapy agent nivolumab to include advanced non-squamous non-small-cell lung cancer.

Everolimus Effective for Certain Neuroendocrine Tumors

This slide show features some of the top highlights on neuroendocrine tumors, breast cancer, and renal cell carcinoma to come out of the 2015 European Cancer Congress in Vienna.

A 47-year-old man presents with shortness of breath and is found to have an anterior mediastinal mass. A biopsy is performed. What is your diagnosis?

Possibly due to a higher prevalence of indoor tanning, skin cancer rates are higher among gay and bisexual men compared to their heterosexual.

Minimally invasive laparoscopic-assisted surgery did not result in better outcomes compared to open surgery for rectal cancer, according to two clinical trials.

Allogeneic HSCT may be the best treatment option in older patients with acute myeloid leukemia who obtain first complete remission after induction chemotherapy.

A simple one-question tool may help oncologists more accurately predict cancer patients’ prognoses and know when to initiate end-of-life discussions.

By clicking Accept, you agree to become a member of the UBM Medica Community.